Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/7/24 16:01 | 4/3/24 | RXRX | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | 4 | S.dm | -3,498 | 8.86 | 0 | -395 | 1,044 | M | |||||||||||||||
6/3/24 18:31 | 5/30/24 | RXRX | Health | BioPrd | Biological Products, (No Diag | Marriott Tina | UT | O | P,COO | 6 | M.d | 150 | 5.36 | 0 | 28 | 5 | 640 | D | ||||||||||||||
6/3/24 18:31 | 5/30/24 | RXRX | Health | BioPrd | Biological Products, (No Diag | Marriott Tina | UT | O | P,COO | 6 | S.d | -150 | 5.36 | 0 | -28 | 640 | D | |||||||||||||||
5/30/24 18:41 | 5/28/24 | RXRX | Health | BioPrd | Biological Products, (No Diag | Borgeson Blake | UT | D | 6 | S | -804 | 9.36 | 0 | -86 | 7,253 | D | ||||||||||||||||
4/18/24 17:12 | 4/16/24 | RXRX | Health | BioPrd | Biological Products, (No Diag | Secora Michael | UT | O | CFO | 4 | M.dm | 1,237 | 4.99 | 0 | 248 | 25 | 1,231 | D | ||||||||||||||
4/18/24 17:12 | 4/16/24 | RXRX | Health | BioPrd | Biological Products, (No Diag | Secora Michael | UT | O | CFO | 4 | S.dm | -1,237 | 4.99 | 0 | -248 | 1,231 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |